Evidence map›Paper›PMID 24742886›Full record

ArticleEuropean heart journal2014

Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.

Nicolas Amabile, Susan Cheng, Jean Marie Renard, Martin G Larson, Anahita Ghorbani, Elizabeth McCabe, Gabriel Griffin, Coralie Guerin, Jennifer E Ho, Stanley Y Shaw and 5 more

Registry-linked trialAbstract read
In one paragraph

Article in European heart journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02937922 (Effect of Aerobic Exercise, Resistance or Combined in Endothelial Injury in Hypertensive Patients), which is not on this map. Cited by 110 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02937922 nacompletednot on this mapstarted 2016, after this paper: background citation

Effect of Aerobic Exercise, Resistance or Combined in Endothelial Injury in Hypertensive Patients

TypeinterventionalSponsorInstituto de Cardiologia do Rio Grande do SulRan2016 to 2020Enrolled33ConditionsHypertension, HealthyArmsAEROBIC, RESISTANCE, COMBINED
3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Endothelial Function Biomarkers in Hypertension.Current medicinal chemistry · 2025
    Review

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nicolas AmabileINSERM, U970, Paris Cardiovascular Research Center - PARCC, 56 Rue Leblanc, 75737 Paris cedex 15, France Université Paris Descartes, Sorbonne Paris Cité, UMR-S970 Paris, France.
Susan ChengFramingham Heart Study, Framingham, MA, USA Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Jean Marie RenardINSERM, U970, Paris Cardiovascular Research Center - PARCC, 56 Rue Leblanc, 75737 Paris cedex 15, France Université Paris Descartes, Sorbonne Paris Cité, UMR-S970 Paris, France.
Martin G LarsonFramingham Heart Study, Framingham, MA, USA Department of Mathematics and Statistics, Boston University, Boston, MA, USA.
Anahita GhorbaniCardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Elizabeth McCabeDepartment of Mathematics and Statistics, Boston University, Boston, MA, USA Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Gabriel GriffinDuke University School of Medicine, Durham, NC, USA.
Coralie GuerinINSERM, U970, Paris Cardiovascular Research Center - PARCC, 56 Rue Leblanc, 75737 Paris cedex 15, France Université Paris Descartes, Sorbonne Paris Cité, UMR-S970 Paris, France.
Jennifer E HoFramingham Heart Study, Framingham, MA, USA Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
Stanley Y ShawCardiology Division, Massachusetts General Hospital, Boston, MA, USA Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.
Kenneth S CohenSection of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USA.
Ramachandran S VasanFramingham Heart Study, Framingham, MA, USA Sections of Preventive Medicine and Cardiology, Boston University School of Medicine, Boston, MA, USA.
Alain TedguiINSERM, U970, Paris Cardiovascular Research Center - PARCC, 56 Rue Leblanc, 75737 Paris cedex 15, France Université Paris Descartes, Sorbonne Paris Cité, UMR-S970 Paris, France.
Chantal M BoulangerINSERM, U970, Paris Cardiovascular Research Center - PARCC, 56 Rue Leblanc, 75737 Paris cedex 15, France Université Paris Descartes, Sorbonne Paris Cité, UMR-S970 Paris, France chantal.boulanger@inserm.fr thomas.j.wang@vanderbilt.edu.
Thomas J WangFramingham Heart Study, Framingham, MA, USA Cardiology Division, Massachusetts General Hospital, Boston, MA, USA Division of Cardiovascular Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, 383 Preston Research Building, Nashville, TN 37232, USA chantal.boulanger@inserm.fr thomas.j.wang@vanderbilt.edu.

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Genome-wide Association Study of Cardiac Structure and FunctionR01HL093328 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAMACHANDRAN, VASAN S · 2008 to 2011
$2.4M
Endothelial Progenitor Cells: Clinical PrognosisR01HL083197 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI WANG, THOMAS J. · 2006 to 2009
$1.9M
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
NCATS NIH HHS UL1 TR000430NHLBI NIH HHS N01-HC-25195NHLBI NIH HHS R01-HL083197NHLBI NIH HHS R01-HL-08675NHLBI NIH HHS R01-HL93328
6 · The paper itself

Abstract

objectiveTo examine the relation of endothelial microparticles (EMPs) with cardiometabolic risk in the community.

backgroundCirculating EMPs are small membrane vesicles released after endothelial cell injury. Endothelial microparticles are reportedly increased among individuals with a high burden of cardiovascular risk factors. However, prior investigations have been limited to small, highly selected samples.

methodsWe studied 844 individuals without a history of cardiovascular disease in the Framingham Offspring cohort (mean age 66 ± 9 years, 57% women). We used standardized flow cytometry methods to identify and quantify circulating CD144+ and CD31+/CD41- EMPs. We then used multivariable regression analyses to investigate the relations of EMP phenotypes with cardiovascular and metabolic risk factors.

resultsIn multivariable analyses, the following cardiovascular risk factors were associated with one or more of the circulating EMP populations: hypertension (P = 0.025 for CD144+,), elevated triglycerides (P = 0.002 for CD144+, P < 0.0001 for CD31+/CD41-), and metabolic syndrome (P < 0.0001 for CD144+,). Overall, each tertile increase in the Framingham risk score corresponded to a 9% increase in log-CD31+/CD41- EMPs (P = 0.022). Furthermore, the presence of hypertriglyceridaemic waist status was associated with 38% higher levels of CD144+ EMPs (P < 0.0001) and 46% higher levels of CD31+/CD41- EMPs (P < 0.0001).

conclusionIn a large community-based sample, circulating EMP levels were associated with the presence of cardiometabolic risk factors, particularly dyslipidaemia. These data underscore the potential influence of high-risk metabolic profiles on endothelial integrity.

Indexed as

AgedAntigens, CDCardiovascular DiseasesCell-Derived MicroparticlesEndothelial CellsEndothelium, VascularFemaleHumansLongitudinal StudiesMaleMetabolic SyndromeRisk FactorsAntigens, CDCardiovascular risk factorsEndotheliumMicroparticles

Identifiers

PMID24742886
PMCPMC4223610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.